Antibody-Cytokine Combinations With Philogen's Dr. Dario Neri
Business Of Biotech · 44 minutes ·

Antibody-Cytokine Combinations With Philogen's Dr. Dario Neri

Swiss-Italian biopharma company Philogen was co-founded in 1996 by three brothers, all of them PhDs. This unique family affair has fueled the development of an incredibly deep and advanced pipeline of no fewer than ten  therapeutic products, most of them in oncology, contributing to 16 active clinical trials, three of them at Phase 3. On this episode of the Business of Biotech, co-founder, CEO, and CSO Prof. Dario Neri shares the incredible story of the company's progress and explains Philogen's approach to  delivering bioactive agents to the site of disease using antibodies or small organic ligands, thus increasing  therapeutic activity and helping spare normal tissues. 

Comments (0)

You Must Be Logged In To Comment

Similar podcasts

Oncology Today with Dr Neil Love

Life Sciences Connect

Explore Life Sciences

The Cancer Pod: Integrative Oncology Talk

Cancer Stories: The Art of Oncology

Tasty Combinations

Management Information Science

Understanding Childhood Cancer With Dr Geoff